Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q3 2022 Earnings Call Transcript November 8, 2022
Voyager Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.45, expectations were $-0.32.
Operator: Good morning, and welcome to Voyager Therapeutics Third Quarter 2022 Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that the call is being recorded at the company’s request. A replay of...
